Frias, Juan P. Auerbach, Pernille Bajaj, Harpreet S. and Fukushima, Yasushi Lingvay, Ildiko Macura, Stanislava and Sondergaard, Anette L. Tankova, I, Tsvetalina Tentolouris, Nikolaos Buse, John B., Efficacy and safety of once-weekly semaglutide 2.0 mg versus 1.0 mg in
patients with type 2 diabetes (SUSTAIN FORTE): a double-blind,
randomised, phase 3B trial, The Lancet Diabetes & Endocrinology, (9), 563-574, 2021, EXCERPTA MEDICA INC-ELSEVIER SCIENCE INC, 2213-8587, 2213-8595